Upstate Active Clinical Trials
Study Title:
A Phase I-II, Randomized, Double-Blind, Study to Evaluate the Safety, Tolerability, and Immunogenicity of Different Formulations of V114 in Healthy Adults and InfantsWhat is the purpose of the study? (in Layman's terms, please describe the study)
The purpose of this study is to:• Test the safety and tolerability of 4 different formulations of the research study vaccine, V114.
• Test the immune system response to the study vaccine, V114.
Upstate Institutional Review Board (IRB) Number:
784386Study/Protocol ID:
V114-005-00Study Phase:
Phase I-IIPatient Age Group:
ChildrenPrincipal Investigator:
Leonard B WeinerWho can I contact for more information?
Name: Kristen Fluno
Phone: 315-464-6331
Email: flunok@upstate.edu